By Andrea Anderson

NEW YORK (GenomeWeb News) – By profiling genomic patterns of a DNA-binding protein called PBX1 in breast cancer cells, Dartmouth Medical School researchers have shown that it serves as a "pioneer factor," paving the way for the estrogen receptor-positive breast cancer proliferation in response to the estrogen hormone.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.